Skip to content

Synthetic Biology funding

October 2026

Research funding

Engineering Biology Access to Infrastructure Pilot

Innovate UK

Closes

Career stage
Not stated
Hosted in
United Kingdom
How to apply
Institution applies

A UK registered SME must lead or apply alone. Funded work must take place in the UK and include a UK partner or subcontractor with relevant scale-up facilities.

BiotechnologyBioprocess Engineering

November 2026

Research funding

Engineering Biology Collaborative R&D: Round 3

Innovate UK

Closes

Career stage
Not stated
Hosted in
United Kingdom
How to apply
Institution applies

A UK-registered business of any size must lead a collaboration that includes at least one UK-registered SME claiming grant funding. Academic institutions cannot lead. The project must include at least one named downstream end user and funded work must be carried out mainly in the UK with UK exploitation of results.

Computational BiologyGenetic EngineeringBiotechnology+1 more

December 2026

Research funding

UK-Germany Bilateral Collaborative R&D: Round 5

Innovate UK / UK Research and Innovation

Closes

Amount
£100,000 – £350,000
Career stage
Not stated
Hosted in
United Kingdom, Germany
How to apply
Institution applies

A UK-registered SME must lead and collaborate with a legally separate, non-linked German SME applying to ZIM. UK businesses of any size, academic institutions and research and technology organisations may collaborate. German partners receive German ZIM funding through a separate application, not Innovate UK funding. Selection is required by both funding bodies.

BiotechnologyEngineeringEnergy Engineering
Research funding

Engineering Biology Investor Partnerships round 1

Innovate UK

Closes

Amount
£250,000 – £2,000,000
Career stage
Not stated
Hosted in
United Kingdom
How to apply
Institution applies

Single UK-registered SME undertaking experimental development in engineering biology. One application per business. The proposal needs a route to market and growth, and aligned investment through a designated lead investor. Fundamental research, clinical trials, preclinical therapeutic evaluation and large capital infrastructure are excluded.

Biotechnology
No more open calls.

We use cookies for analytics.